Skip to main content

Pulmonx Corp

LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001127537

In the last 90 days, Pulmonx Corp insiders filed 0 open-market purchases and 4 sales; 107 institutions reported holding it in 13F filings for Q2 2026, worth $34.1M in total; no superinvestor holds it.

Q1 2022 vs. Q4 2021

How the institutions holding Pulmonx Corp changed between Q4 2021 and Q1 2022.

All holders in Q1 2022All holders in Q4 2021

13F holders of LUNG: Q4 2021 compared with Q1 2022
MeasureQ4 2021Q1 2022Change
Holders114109−5
Shares32.0M34.7M+2.66M (+8.3%)
Value$1.03B$861.1M−$166.7M (−16.2%)

New holders (15)

Institutions that held Pulmonx Corp at the end of Q1 2022 but not at the end of Q4 2021.

Institutions new to LUNG in Q1 2022
InstitutionSharesValue% of portfolio
William Blair Investment Management, LLC693,839$17.2M0.05%
Susquehanna International Group, LLP181,928$4.51M0.01%
Millrace Asset Group, Inc.78,859$1.96M1.42%
Jane Street Group, LLC62,453$1.55M0.00%
Two Sigma Investments, LP28,835$715.0K0.00%
PDT Partners, LLC14,225$353.0K0.03%
Barclays PLC6,329$157.0K0.00%
Amalgamated Bank4,251$105.0K0.00%
Amalgamated Financial Corp.4,251$105.0K0.00%
Simplex Trading, LLC3,545$87.0K0.00%
Emerald Advisers, LLC2,000$50.0K0.00%
Point72 Hong Kong Ltd1,613$40.0K0.00%
Signaturefd, LLC199$5.00K0.00%
Capital Advisors, Ltd. LLC25$1.00K0.00%
Lindbrook Capital, LLC17$00.00%

Sold out (20)

Institutions that held Pulmonx Corp at the end of Q4 2021 and filed for Q1 2022 without it.